HomeATOS • NASDAQ
Atossa Therapeutics Inc
Follow
$0.60
6.44%
After Hours:(3.14%)+0.019
$0.62
Closed: Apr 4, 7:38:30 PM GMT-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.15M | -20.71% |
Net income | -6.35M | 18.15% |
Net profit margin | — | — |
Earnings per share | -0.05 | 16.67% |
EBITDA | -7.15M | 20.63% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 71.08M | -19.64% |
Total assets | 76.44M | -20.58% |
Total liabilities | 4.97M | -5.14% |
Total equity | 71.48M | — |
Shares outstanding | 129.17M | — |
Price to book | 1.17 | — |
Return on assets | -22.93% | — |
Return on capital | -24.63% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -6.35M | 18.15% |
Cash from operations | -7.05M | -26.57% |
Cash from investing | 0.00 | — |
Cash from financing | 3.37M | — |
Net change in cash | -3.68M | 33.91% |
Free cash flow | -5.55M | -60.64% |
Previous close
$0.64
Day range
$0.60 - $0.64
Year range
$0.60 - $2.30
Market cap
77.95M USD
Avg Volume
538.24K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2008
Headquarters
Website
Employees
15
